{
    "clinical_study": {
        "@rank": "73743", 
        "arm_group": [
            {
                "arm_group_label": "preconception", 
                "arm_group_type": "Active Comparator", 
                "description": "Participants will be included according to their first outpatient visiting time. Women with TSH\u226597.5%th and/or FT4\u22642.5%th will accept levothyroxine 150ug daily and follow-up every 4 weeks. Medical records include: a)maternal thyroid function at enrollment; b) Levothyroxine: length, dose, drug adverse effects; c)Early trimester of pregnancy: Down's screening; d)2nd trimester of pregnancy: fetal echocardiography; e)Whole course of pregnancy: maternal complications, maternal blood pressure at each visit, fetal growth; f)Pregnancy outcome: type of delivery, length of labor, type and timing of analgesia/anesthesia, Apgar scores, postpartum hemorrhage, fetal complications; g)Offspring cognitive assessment at 0-3 years old"
            }, 
            {
                "arm_group_label": "early conception", 
                "arm_group_type": "Active Comparator", 
                "description": "Participants will be included according to their first outpatient visiting time before 15+6 gestational week. Women with TSH\u226597.5%th and/or FT4\u22642.5%th will accept levothyroxine 150ug daily and follow-up every 4 weeks. Medical records include: a)maternal thyroid function at enrollment; b) Levothyroxine: length, dose, drug adverse effects; c)Early trimester of pregnancy: Down's screening; d)2nd trimester of pregnancy: fetal echocardiography; e)Whole course of pregnancy: maternal complications, maternal blood pressure at each visit, fetal growth; f)Pregnancy outcome: type of delivery, length of labor, type and timing of analgesia/anesthesia, Apgar scores, postpartum hemorrhage, fetal complications; g)Offspring cognitive assessment at 0-3 years old"
            }, 
            {
                "arm_group_label": "late conception", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Participants will be included according to their first outpatient visiting time after 16 gestational week. Women with TSH\u226597.5%th and/or FT4\u22642.5%th will accept levothyroxine 150ug daily and follow-up every 4 weeks. Medical records include: a)maternal thyroid function at enrollment; b) Levothyroxine: length, dose, drug adverse effects; c)Early trimester of pregnancy: Down's screening; d)2nd trimester of pregnancy: fetal echocardiography; e)Whole course of pregnancy: maternal complications, maternal blood pressure at each visit, fetal growth; f)Pregnancy outcome: type of delivery, length of labor, type and timing of analgesia/anesthesia, Apgar scores, postpartum hemorrhage, fetal complications; g)Offspring cognitive assessment at 0-3 years old"
            }
        ], 
        "brief_summary": {
            "textblock": "To assess the effect of universal preconception hypothyroidism for maternal pregnancy\n      outcome, and 0-3yrs offspring neurocognitive ability and IQ score."
        }, 
        "brief_title": "Preconceptional Thyroid Screening and Childhood Nerocognitive Function", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Hypothyroidism", 
        "condition_browse": {
            "mesh_term": "Hypothyroidism"
        }, 
        "detailed_description": {
            "textblock": "Epidemic evidence and animal studies suggested that hypothyroidism is related with maternal\n      pregnancy outcome, offspring cognitive ability. Negro's study found improved maternal health\n      in those screened in early trimester; while Lazarus et al. reported  no significant\n      offspring IQ score at 3yrs in universal screening in early trimester. Currently, it lacks\n      evidence of universal pre-conception screening for maternal pregnancy outcome and offspring\n      cognitive development, motivation ability, attention. China Governmental Health Department\n      has included thyroid function screening into preconception in 2011. The investigators\n      hypothesize that pre-conception effective treatment may be helpful for decrease possible\n      negative effects on maternal and offspring health, instead of early trimester."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Preconceptional group\uff1aTSH \u2265 97.5%th and/or FT4 \u2264 2.5%th\n\n          2. age: 18-55\n\n          3. those who can obey the rules of this study and assign the consent\n\n        Exclusion Criteria:\n\n          1. age: less than 18 or more than 55\n\n          2. multiple pregnancy\n\n          3. thyroid tumor disease history\n\n          4. those who cannot obey the rules of this study"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "55 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "600", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 20, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01744743", 
            "org_study_id": "12XD1401300"
        }, 
        "intervention": {
            "arm_group_label": [
                "preconception", 
                "early conception", 
                "late conception"
            ], 
            "description": "Women with TSH\u226597.5%th and/or FT4\u22642.5%th will accept levothyroxine 150ug daily and follow-up every 4 weeks.", 
            "intervention_name": "levothyroxine", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "preconception", 
            "hypothyroidism", 
            "neurocognitive development"
        ], 
        "lastchanged_date": "December 7, 2012", 
        "location": {
            "contact": {
                "email": "xiaotianli555@163.com", 
                "last_name": "Xiaotian Li, MD, PhD", 
                "phone": "862163455050"
            }, 
            "contact_backup": {
                "email": "qj_zhou@163.com", 
                "last_name": "Qiongjie Zhou, MD", 
                "phone": "862163455050"
            }, 
            "facility": {
                "address": {
                    "city": "Shanghai", 
                    "country": "China", 
                    "state": "Shanghai", 
                    "zip": "200011"
                }, 
                "name": "Obstetrics and Gynecology Hospital, Fudan University"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "3", 
        "official_title": "Preconceptional Thyroid Screening and Childhood Nerocognitive Function", 
        "other_outcome": {
            "description": "preeclampsia, GDM, maternal death rate, maternal hemorrhage rate", 
            "measure": "Incidence of maternal complications", 
            "safety_issue": "No", 
            "time_frame": "up to 42 days postpartumn"
        }, 
        "overall_contact": {
            "email": "xiaotianli555@163.com", 
            "last_name": "Xiaotian Li, MD, PhD", 
            "phone": "862163455050"
        }, 
        "overall_contact_backup": {
            "email": "qj_zhou@163.com", 
            "last_name": "Qiongjie Zhou, MD", 
            "phone": "862163455050"
        }, 
        "overall_official": {
            "affiliation": "Obstetrics and Gynecology Hospital, Fudan University", 
            "last_name": "Xiaotian Li, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Science and Technology Commission of Shanghai Municipality", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Peabody scale, Griffith scale", 
                "measure": "Offspring neurocognitive assessment at 0-3 yrs", 
                "safety_issue": "No", 
                "time_frame": "3 months, 6 months, 1 year, 2 years, 3 years"
            }, 
            {
                "description": "Wechsler Preschool Intelligence Scale at 1, 2, 3-year-old", 
                "measure": "Offspring IQ assessment at 0-3 yrs", 
                "safety_issue": "No", 
                "time_frame": "3 months, 6 months, 1 year, 2 years, 3 years"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01744743"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Fudan University", 
            "investigator_full_name": "Xiaotian Li", 
            "investigator_title": "Vice president, Cheif of Obstetrics Department, Obstetrics and Gynecology Hospital", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "neonatal hypothyroid function, NICU rate, neonatal death rate", 
            "measure": "Incidence of neonatal hypothyroid and complications", 
            "safety_issue": "No", 
            "time_frame": "up to 28 days of birth"
        }, 
        "source": "Fudan University", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Shanghai Municipal Science and Technology Commission", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Shanghai Municipal Health Bureau", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Fudan University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2011", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "December 2012"
    }
}